Borderline Personality Disorder Treatment Study

Groundbreaking Research Opens New Possibilities

Cutting-Edge Study Yields Hope

In a groundbreaking development, the first randomized controlled trial has been conducted to evaluate the effectiveness of ketamine infusions for treating treatment-resistant depression with borderline personality disorder (BPD). This study revolutionizes the approach to a condition that has long perplexed healthcare professionals.